Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Personalis, Inc.
< Previous
1
2
3
Next >
Analysis from TRACERx Study Reveals More Sensitive and Earlier ctDNA Detection in Lung Cancer Patients by Personalis' MRD Technology
October 21, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Announces Late-Breaking NeXT Personal Abstract and Proffered Paper Presentation at ESMO 2023
October 19, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Appoints Former Roche Diagnostics and GRAIL Executive Deepshikha Bhandari as SVP, Regulatory, Quality and Clinical Compliance
October 18, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis to Present at the 21st Annual Morgan Stanley Global Healthcare Conference
August 29, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 24, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Reports Second Quarter 2023 Financial Results
August 08, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis to Participate at Upcoming Investor Conferences
August 01, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis to Announce Second Quarter 2023 Financial Results
July 25, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Files Second Patent Infringement Suit Against Foresight Diagnostics
June 26, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Dr. Kenneth J. Widder Joins Personalis Board of Directors
June 13, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Announces Two Abstracts Accepted for Presentation at ASCO 2023
May 30, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer
May 16, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Reports First Quarter 2023 Financial Results
May 03, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis, ABRCC, and Criterium Announce Major Prospective Clinical Trial for Residual and Recurrent Disease Detection in Triple Negative Breast Cancer
May 02, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis to Announce First Quarter 2023 Financial Results
April 19, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis to Participate at the 22nd Annual Needham Virtual Healthcare Conference
April 05, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Joins Top UK Cancer Research Organizations to Evaluate Earlier Cancer Recurrence Detection Through Groundbreaking Study
April 05, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Announces Four Abstracts Accepted for Presentation at AACR Annual Meeting 2023
March 22, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Selected for Clinical Research After Successful Evaluation of Whole Genome-Based Molecular Residual Disease Assay
March 07, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Appoints Christopher Hall as Chief Executive Officer
March 02, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Reports Fourth Quarter and Full Year 2022 Financial Results
February 23, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis to Announce Fourth Quarter and Full Year 2022 Financial Results
February 09, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis to Participate at Upcoming Investor Conferences
February 06, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials
February 03, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
MRNA
PSNL
Personalis Reports Preliminary Fourth Quarter and Full Year 2022 Revenue
January 04, 2023
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 16, 2022
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Announces CEO Retirement and Transition
December 14, 2022
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Cancer Assay NeXT Personal Ranks #1 on The Scientist’s Top 10 Innovations of 2022
December 12, 2022
From
Personalis, Inc.
Via
Business Wire
Personalis and UCSF to Study Clinical Utility of ctDNA for Treatment Response in Colorectal Cancer
November 30, 2022
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis to Present at the 34th Annual Piper Sandler Healthcare Conference
November 21, 2022
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.